{"id":1699035,"date":"2025-05-03T05:17:47","date_gmt":"2025-05-03T05:17:47","guid":{"rendered":"https:\/\/teknomers.com\/es\/abril-de-2025-los-analistas-ven-el-potencial-en-novo-nordisk-share\/"},"modified":"2025-05-03T05:17:51","modified_gmt":"2025-05-03T05:17:51","slug":"abril-de-2025-los-analistas-ven-el-potencial-en-novo-nordisk-share","status":"publish","type":"post","link":"https:\/\/teknomers.com\/es\/abril-de-2025-los-analistas-ven-el-potencial-en-novo-nordisk-share\/","title":{"rendered":"Abril de 2025: los analistas ven el potencial en Novo Nordisk Share"},"content":{"rendered":"


\n<\/p>\n

Estas son las evaluaciones de expertos de Novo Nordisk Share.<\/p>\n

\n

En abril de 2025, 19 expertos analizaron el Novo Nordisk Share.<\/p>\n

14 analistas recomiendan la acci\u00f3n de Novo Nordisk con la compra, 3 expertos recomiendan mantener la acci\u00f3n, 2 analistas recomiendan vender el Novo Nordisk Share.<\/p>\n

Los analistas establecen el tiempo corto promedio en 729.58 DKK. Esto corresponde a un aumento de 305.23 DKK para el curso CPH actual de Novo Nordisk en la cantidad de DKK 424.35.<\/p>\n

La tendencia de calificaci\u00f3n de 6 meses indica la compra.<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Analista<\/th>\n\nPrecio objetivo<\/th>\nObjetivo de distancia<\/th>\nFecha<\/th>\n<\/tr>\n<\/thead>\n
JP Morgan Chase & Co.<\/td>\n<\/td>\n1,000.00 DKK<\/td>\n135.65<\/td>\n30\/04\/2025<\/td>\n<\/tr>\n
Deutsche Bank AG<\/td>\n<\/td>\n750.00 DKK<\/td>\n76.74<\/td>\n29\/04\/2025<\/td>\n<\/tr>\n
Goldman Sachs Group Inc.<\/td>\n<\/td>\n825.00 DKK<\/td>\n94.41<\/td>\n28\/04\/2025<\/td>\n<\/tr>\n
UBS AG<\/td>\n<\/td>\n750.00 DKK<\/td>\n76.74<\/td>\n28\/04\/2025<\/td>\n<\/tr>\n
UBS AG<\/td>\n<\/td>\n750.00 DKK<\/td>\n76.74<\/td>\n22\/04\/2025<\/td>\n<\/tr>\n
Deutsche Bank AG<\/td>\n<\/td>\n750.00 DKK<\/td>\n76.74<\/td>\n22\/04\/2025<\/td>\n<\/tr>\n
Goldman Sachs Group Inc.<\/td>\n<\/td>\n825.00 DKK<\/td>\n94.41<\/td>\n22\/04\/2025<\/td>\n<\/tr>\n
Investigaci\u00f3n \u00e1mbar<\/td>\n<\/td>\n620.00 DKK<\/td>\n46.11<\/td>\n17\/04\/2025<\/td>\n<\/tr>\n
Jefferies & Company Inc.<\/td>\n<\/td>\n415.00 DKK<\/td>\n-2.20<\/td>\n17\/04\/2025<\/td>\n<\/tr>\n
JP Morgan Chase & Co.<\/td>\n<\/td>\n1,000.00 DKK<\/td>\n135.65<\/td>\n17\/04\/2025<\/td>\n<\/tr>\n
Capital de Barclays<\/td>\n<\/td>\n700.00 DKK<\/td>\n64.96<\/td>\n16\/04\/2025<\/td>\n<\/tr>\n
UBS AG<\/td>\n<\/td>\n750.00 DKK<\/td>\n76.74<\/td>\n04\/08\/2025<\/td>\n<\/tr>\n
Investigaci\u00f3n \u00e1mbar<\/td>\n<\/td>\n620.00 DKK<\/td>\n46.11<\/td>\n07.04.2025<\/td>\n<\/tr>\n
Deutsche Bank AG<\/td>\n<\/td>\n750.00 DKK<\/td>\n76.74<\/td>\n07.04.2025<\/td>\n<\/tr>\n
UBS AG<\/td>\n<\/td>\n750.00 DKK<\/td>\n76.74<\/td>\n07.04.2025<\/td>\n<\/tr>\n
UBS AG<\/td>\n<\/td>\n750.00 DKK<\/td>\n76.74<\/td>\n04.04.2025<\/td>\n<\/tr>\n
Investigaci\u00f3n \u00e1mbar<\/td>\n<\/td>\n620.00 DKK<\/td>\n46.11<\/td>\n04.04.2025<\/td>\n<\/tr>\n
Goldman Sachs Group Inc.<\/td>\n<\/td>\n822.00 DKK<\/td>\n93.71<\/td>\n04.04.2025<\/td>\n<\/tr>\n
Jefferies & Company Inc.<\/td>\n<\/td>\n415.00 DKK<\/td>\n-2.20<\/td>\n04.04.2025<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

Editor Finance.net<\/p>\n<\/div>\n

\n

Productos de apalancamiento seleccionados en Novo Nordisk<\/h2>\n

Con Knock-Outs, los inversores especulativos pueden participar desproporcionadamente en los movimientos de precios. Simplemente elija la palanca deseada y le mostraremos productos abiertos adecuados en Novo Nordisk<\/p>\n

La palanca debe estar entre 2 y 20<\/p>\n

Publicidad<\/span><\/div>\n


\n
ttn-es-28<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Estas son las evaluaciones de expertos de Novo Nordisk Share. En abril de 2025, 19 expertos analizaron el<\/p>\n","protected":false},"author":1,"featured_media":1487266,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[2493,4786,36,146013,146012,15627,13582,8309],"class_list":["post-1699035","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finanzas","tag-abril","tag-analistas","tag-los","tag-nordisk","tag-novo","tag-potencial","tag-share","tag-ven"],"_links":{"self":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/1699035","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/comments?post=1699035"}],"version-history":[{"count":0,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/posts\/1699035\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media\/1487266"}],"wp:attachment":[{"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/media?parent=1699035"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/categories?post=1699035"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/teknomers.com\/es\/wp-json\/wp\/v2\/tags?post=1699035"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}